Drug Type Small molecule drug |
Synonyms- |
Action partial agonists, antagonists, modulators |
Mechanism D1 receptor partial agonists(Dopamine D1 receptor partial agonists), D3 receptor antagonists(Dopamine D3 receptor antagonists), α2C-AR modulators(Alpha-2c adrenergic receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cognition Disorders | Preclinical | United States | 01 Dec 2025 | |
| Depressive Disorder | Preclinical | United States | 01 Dec 2025 |





